dMY Squared Technology (DMYY) 10-Q 15 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 15, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Entity File Number	001-41519
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Fiscal Period Focus	Q1
Entity Registrant Name	DMY SQUARED TECHNOLOGY GROUP, INC.
Entity Central Index Key	0001915380
Entity Tax Identification Number	88-0748933
Entity Incorporation, State or Country Code	MA
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	1180 North Town Center Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89144
City Area Code	702
Local Phone Number	781-4313
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	DMYY
Security Exchange Name	NYSEAMER
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,319,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,579,750
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
Trading Symbol	DMYY.U
Security Exchange Name	NYSEAMER
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol	DMYY.WS
Security Exchange Name	NYSEAMER

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 1,216	$ 238,539
Prepaid expenses	373,949	565,472
Total current assets	375,165	804,011
Investments held in Trust Account	65,388,153	64,703,943
Total Assets	65,763,318	65,507,954
Current liabilities:
Accounts payable	273,410	170,837
Accrued expenses	272,400	273,619
Corporate tax payable	235,338	155,655
Income tax payable	237,969	86,214
Total current liabilities	1,019,117	686,325
Overfunding loans	947,850	947,850
Derivative warrant liabilities	1,873,690	2,478,110
Deferred underwriting commissions	2,211,650	2,211,650
Total Liabilities	6,052,307	6,323,935
Commitments and Contingencies
Class A common stock, $0.0001 par value; 35,000,000 shares authorized; 6,319,000 shares subject to possible redemption at approximately $10.26 and $10.19 per share as of March 31, 2023 and December 31, 2022, respectively	64,814,846	64,362,074
Shareholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of March 31, 2023 and December 31, 2022	0	0
Additional paid-in capital	0	0
Accumulated deficit	(5,103,993)	(5,178,213)
Total shareholders' deficit	(5,103,835)	(5,178,055)
Total Liabilities and Shareholders' Deficit	65,763,318	65,507,954
Common Class A [Member]
Current liabilities:
Class A common stock, $0.0001 par value; 35,000,000 shares authorized; 6,319,000 shares subject to possible redemption at approximately $10.26 and $10.19 per share as of March 31, 2023 and December 31, 2022, respectively	64,814,846	64,362,074
Shareholders' Deficit:
Common Stock	0	0
Common Class B [Member]
Shareholders' Deficit:
Common Stock	$ 158	$ 158

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Sep. 29, 2022	Mar. 16, 2022
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Temporary equity redemption price per share	$ 10.15
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	5,000,000	5,000,000
Common stock shares issued	1,579,750	1,579,750		1,725,000
Common stock shares outstanding	1,579,750	1,579,750	1,725,000	1,725,000
Common Class A [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	35,000,000	35,000,000
Common stock shares issued	6,319,000	6,319,000
Common stock shares outstanding	6,319,000	6,319,000
Temporary equity, shares outstanding	6,319,000	6,319,000
Temporary equity redemption price per share	$ 10.26	$ 10.19
Non-redeemable Class A Common Stock [Member]
Common stock shares issued	0	0
Common stock shares outstanding	0	0

Condensed Statements Of Operati

Condensed Statements Of Operations - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023
General and administrative expenses	$ 41,000	$ 530,235
Corporate tax expenses	0	79,683
Loss from operations	(41,000)	(609,918)
Other income :
Interest income on operating account	0	35
Interest income from investments held in Trust Account	0	684,210
Change in fair value of derivative warrant liabilities	0	604,420
Total other income	0	1,288,665
Net income (loss) before provision for income taxes	(41,000)	678,747
Provision for income taxes	0	151,755
Net income (loss)	(41,000)	526,992
Common Class A [Member]
Other income :
Net income (loss)	$ 0	$ 421,594
Weighted average shares outstanding, basic	0	6,319,000
Weighted average shares outstanding, diluted	0	6,319,000
Basic net income (loss) per share	$ 0	$ 0.07
Diluted net income (loss) per share	$ 0	$ 0.07
Common Class B [Member]
Other income :
Net income (loss)	$ (41,000)	$ 105,398
Weighted average shares outstanding, basic	1,500,000	1,579,750
Weighted average shares outstanding, diluted	1,500,000	1,579,750
Basic net income (loss) per share	$ (0.03)	$ 0.07
Diluted net income (loss) per share	$ (0.03)	$ 0.07

Condensed Statements Of Changes

Condensed Statements Of Changes In Shareholders' Deficit - USD ($)		Total	Common Class B [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning balance, Shares at Feb. 14, 2022				0
Beginning balance at Feb. 14, 2022		$ 0		$ 0	$ 0	$ 0
Issuance of Class B common stock to Sponsor, Shares	[1],[2]			1,725,000
Issuance of Class B common stock to Sponsor	[1],[2]	25,000		$ 173	24,827
Net income (loss)		(41,000)	$ (41,000)			(41,000)
Ending balance, Shares at Mar. 31, 2022				1,725,000
Ending balance at Mar. 31, 2022		(16,000)		$ 173	24,827	(41,000)
Beginning balance, Shares at Feb. 14, 2022				0
Beginning balance at Feb. 14, 2022		0		$ 0	0	0
Ending balance, Shares at Dec. 31, 2022				1,579,750
Ending balance at Dec. 31, 2022		(5,178,055)		$ 158	0	(5,178,213)
Accretion for Class A common stock to redemption amount		(452,772)			0	(452,772)
Net income (loss)		526,992	$ 105,398			526,992
Ending balance, Shares at Mar. 31, 2023				1,579,750
Ending balance at Mar. 31, 2023		$ (5,103,835)		$ 158	$ 0	$ (5,103,993)
[1]Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of 718,750 shares of Class B common stock for no consideration on September 8, 2022; and (ii) the surrender of 431,250 shares of Class B common stock for no consideration on September 29, 2022; resulting in a decrease in the total number of Class B common stock outstanding to 1,725,000 shares (see Note 4).[2]This number includes up to 225,000 Founder Shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. The underwriter partially exercised its over-allotment option on October 11, 2022 and waived the remainder of its over-allotment option. Accordingly, the Sponsor forfeited 145,250 Founder Shares on October 11, 2022. (see Note 4).

Condensed Statements Of Chang_2

Condensed Statements Of Changes In Shareholders' Deficit (Parenthetical)	Oct. 11, 2022 shares
Common Class B [Member] | Over-Allotment Option [Member]
Stock issued during period number of shares forfeited	145,250

Condensed Statements Of Cash Fl

Condensed Statements Of Cash Flows - USD ($)	2 Months Ended	3 Months Ended	11 Months Ended
	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ (41,000)	$ 526,992
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income from investments held in Trust Account	0	(684,210)
Change in fair value of derivative warrant liabilities	0	(604,420)
General and administrative expenses paid by related party under promissory note	41,000	0
Changes in operating assets and liabilities:
Prepaid expenses	0	191,523
Accounts payable	0	102,573
Accrued expenses	0	(1,219)
Corporate tax payable	0	79,683
Income tax payable	0	151,755
Net cash used in operating activities	0	(237,323)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000	0
Net cash provided by financing activities	25,000	0
Net change in cash	25,000	(237,323)
Cash - Beginning of the period	0	238,539	$ 0
Cash - End of the period	25,000	1,216	$ 238,539
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable	35,100	0
Offering costs included in accrued expenses	$ 238,727	$ 0

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations dMY Squared Technology Group, Inc. (the “Company”) is a blank check company incorporated in Massachusetts. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity for the period from February 15, 2022 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) as described below, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating were Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 2,840,000 warrants (the “Initial private placement warrants”), at a price of $1.00 per Initial private placement warrant to the Sponsor, generating proceeds of approximately $ million (see Note 4). On October 11, 2022, simultaneously with the issuance and sale of the over-allotment units, the Company consummated the sale of an additional In addition, concurrently with the closing of the Initial Public Offering, the Sponsor extended an overfunding loan to the Company in an amount of $ at no interest (the “Initial Overfunding Loan”) to deposit in the Trust Account (as defined below). On October 11, 2022, simultaneously with the sale of the over-allotment units, the Sponsor extended a further overfunding loan to the Company in an aggregate amount of $ Upon the closing of the Initial Public Offering, the Partial Over-Allotment, the Private Placement and the Overfunding Loans, approximately $64.1 million ($10.15 per unit) of the net proceeds of the sale of the units and the private placement warrants and the proceeds from the Overfunding Loans were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and will be invested in United States government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), or the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. The Act. The per-share Note 5). These Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity”. The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $ The Company’s Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Shareholders”) agreed not to propose an amendment to the Articles to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to shareholders’ rights or pre-initial amendment. The S S non-interest If ten per-share The Initial Shareholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.15 . In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $ per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.15 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On November 18, 2022, the Company announced that the holders of the units sold in the Initial Public Offering may elect to separately trade the shares of Class A common stock and Public Warrants commencing on November 21, 2022. Any units not separated will continue to trade on the NYSE American under the symbol “DMYY.U”, and the Class A Common Stock and Warrants will separately trade on the NYSE American under the symbols “DMYY” and “DMYY.WS,” respectively. No fractional Warrants will be issued upon separation of the units and only whole Warrants will trade. Going Concern Consideration As of March 31, 2023, the Company had approximately $1,200 in cash and working capital deficit of approximately $644,000 (including tax obligations of approximately $473,000 that may be paid using investment income earned in Trust Account). Subsequent to December 31, 2022, the Company withdrew $304,000 from the Trust Account to pay for its taxes. Prior to the consummation of the Initial Public Offering, the Company’s liquidity needs were satisfied through the payment of $25,000 from the Sponsor to purchase Founder Shares (as defined in Note 4) and a loan under the Note (as defined in Note 4) in the amount of approximately $145,000. Subsequent to the closing of the Initial Public Offering and the Partial Over-Allotment on October 4, 2022 and October 11, 2022, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. The Company fully repaid the Note balance on October 4, 2022. The Note was no longer available to the Company after closing of its Initial Public Offering. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company funds as needed under Working Capital Loans (see Note 4). The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $ Based upon the analysis above, the Company’s management has determined that it has sufficient borrowing capacity and the Sponsor has financial wherewithal to meet its anticipated obligations through the earlier of the consummation of a Business Combination or through the liquidation date. In connection with the management’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. On On December 27, 2022, the Treasury and Internal Revenue Service (“IRS”) issued a Notice 2023-2 (“Notice”), which provided interim guidance regarding the application of the corporate stock repurchase excise tax until the issuance of proposed regulations. The Notice excluded the distributions upon complete liquidation of a corporation from the base of the excise tax. The Notice also excludes from the scope of the excise tax any distribution made during the taxable year in which a corporation fully liquidates and dissolves, even if a distribution precedes the formal decision to liquidate.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, Article 8 and Article 10 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report Form 10-K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, regularly exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in Trust Account in the accompanying condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, other than for the Overfunding Loan to the Sponsor, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets, either because the short-term nature of the instruments or because the instrument is recognized at fair value. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the condensed statements of operations each reporting period. The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company evaluates embedded conversion features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from the debt host instrument and accounted for as a derivative in accordance with ASC 815. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and will adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the derivative warrant liabilities were charged to operations. Offering costs associated with the Class A common stock were charged against the carrying value of Class A common stock upon the completion of the Initial Public Offering. Class A Common Stock Subject to Possible Redemption As discussed in Note 1, all of the 6,319,000 shares of Class A common stock sold as parts of the units in the Initial Public Offering contain a redemption feature. In accordance with ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. The Company classified all of the shares of Class A common stock as redeemable. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. As of March 31, 2023 and December 31, 2022, the amounts of Class A common stock reflected on the condensed balance sheets are reconciled in the following table: Gross proceeds $ 63,190,000 Less: Proceeds allocated to Public Warrants (379,140 ) Class A shares issuance costs (3,802,072 ) Plus: Accretion of carrying value to redemption value 5,353,286 Class A common stock subject to possible redemption - December 31, 2022 64,362,074 Plus: Accretion of carrying value to redemption value 452,772 Class A common stock subject to possible redemption - March 31, 2023 $ 64,814,846 Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average number of common stock outstanding for the respective period. The Company has not considered the effect of the Public Warrants and the private placement warrants to purchase an aggregate of 6,044,160 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share of common stock for each class of common stock: For the period from For the three months ended February 15, 2022 (inception) March 31, 2023 through March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per common share: Numerator: Allocation of net income (loss) $ 421,594 $ 105,398 $ — $ (41,000 ) Denominator: Basic and diluted weighted average common shares outstanding 6,319,000 1,579,750 — 1,500,000 Basic and diluted net income (loss) per common share $ 0.07 $ 0.07 $ — $ (0.03 ) Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2023 and December 31, 2022, the Company had gross deferred tax assets of approximately $ respectively, which were presented net of a full valuation allowance. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements. Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3—Initial Public Offering On October 4, 2022, the Company consummated its Initial Public Offering of 6,000,000 units at a price of $10.00 per unit, generating gross proceeds of $60.0 million, and incurring offering costs of approximately $3.7 million, of which $2.1 million and approximately $26,000 was for deferred underwriting commissions and offering costs allocated to derivate warrant liabilities, respectively. The Company granted the underwriter in the Initial Public Offering a 45-day Each unit consists of one share of Class A common stock, and one-half 7

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On March 16, 2022, the S shares of the Company’s Class B common stock, par value $ per share (the “Founder Shares”) for an aggregate purchase price of $ Founder Shares, respectively, in each case for no consideration, resulting in the Sponsor owning The Initial Shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) 30-trading 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 2,840,000 Initial private placement warrants, at a price of $1.00 per Initial private placement warrant, generating proceeds of approximately $2.8 million. On October 11, 2022, simultaneously with the issuance and sale of the over-allotment units, the Company consummated the sale of 44,660 Additional private placement warrants at $1.00 per Additional private placement warrant, generating additional gross proceeds of approximately $45,000. Each private placement warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the private placement warrants to the sponsor will be added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the private placement warrants will expire worthless. Except as set forth below, the private placement warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor or their permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their private placement warrants until Related Party Loans Promissory Note to Sponsor On March 3, 2022, the sponsor agreed to loan the Company an aggregate amount of up to $200,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest Overfunding Loans Simultaneously with the closing of the Initial Public Offering, the sponsor extended the Overfunding Loan to the Company in an aggregate amount of $900,000. On October 11, 2022, simultaneously with the sale of the over-allotment units, the Sponsor extended the Additional Overfunding Loan to the Company in an amount of $47,850, for an aggregate outstanding principal amount of $947,850 to be deposited in the Trust Account. The Overfunding Loans will be repaid upon the closing of the initial Business Combination or converted into shares of Class A common stock at a conversion price of $10.00 per share of Class A common stock (or a combination of both), at the Sponsor’s discretion, provided that any such conversion may not occur until after the 60th day following the effective date of the registration statement of which the prospectus in connection with the Initial Public Offering forms a part. If the Company does not complete an initial Business Combination, it will not repay the Overfunding Loans from amounts held in the Trust Account, and its proceeds will be distributed to the Public Shareholders; however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the private placement warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital Loans. Extension Loans As described in Note 1, if the Company extends the time it has to consummate the initial Business Combination to 21 months from the closing of the Initial Public Offering, the Sponsor or its affiliates or designees will be required to extend Extension Loans to the Company in an amount of $ non-interest Administrative Services Agreement On October 4, 2022, the Company entered into an agreement pursuant to which it agreed to pay the sponsor $10,000 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. The Company recorded $30,000 in connection with such fees during the three months ended March 31, 2023 in the accompanying condensed statements of operations. The Company prepaid such fees in full, and as of March 31, 2023 and December 31, 2022, the Company had an unused balance of $20,000 and $50,000 in prepaid expenses recorded in the accompanying condensed balance sheets, respectively. The Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5—Commitments and Contingencies Registration and Shareholder Rights The holders of Founder Shares, private placement warrants and warrants that may be issued upon conversion of Working Capital Loans and the Extension Loans (and any shares of common stock issuable upon the exercise of the private placement warrants or warrants issued upon conversion of the Working Capital Loans and the Extension Loans and upon conversion of the Founder Shares and the Overfunding Loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriter was entitled to an underwriting discount of $0.14 per unit, or approximately $0.8 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.35 per unit, or $2.1 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The underwriter was entitled to an additional fee of approximately $45,000, which was paid upon closing of the Partial Over-Allotment, and approximately $112,000 in deferred underwriting commissions in connection with the consummation of the Partial Over-Allotment.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	3 Months Ended
	Mar. 31, 2023
Disclosure Of Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 6—Derivative Warrant Liabilities As of March 31, 2023 and December 31, 2022, the Company had an aggregate of 6,044,160 warrants outstanding, comprised of 3,159,500 Public Warrants and 2,884,660 private placement warrants. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the sponsor or its affiliates, without taking into account any Founder Shares held by the sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The private placement warrants are identical to the Public Warrants, except that the private placement warrants and the shares of Class A common stock issuable upon exercise of the private placement warrants will not be transferable, assignable or salable until the completion of a Business Combination, subject to certain limited exceptions. Additionally, except as set forth below, the private placement warrants will be non-redeemable Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00 . • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption, referred to as the 30-day • if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00. • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A common stock; and • if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading The “fair market value” of Class A common stock shall mean the volume weighted average price of Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Shareholders' Deficit

Shareholders' Deficit	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	Note 7—Shareholders’ Deficit Preferred Stock Class A Common Stock Class B Common Stock shares of Class B common stock were subject to forfeiture to the Company by the Initial Shareholders for no consideration to the extent that the underwriter’ over-allotment option was not exercised in full or in part, so that the Initial Shareholders would collectively own Common shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class B common stock will have the right to elect all of the Company’s directors prior to the consummation of the initial Business Combination. On any other matter submitted to a vote of the Company’s shareholders, holders of Class B common stock and holders of Class A common stock will vote together as a single class, except as required by applicable law or stock exchange rule. The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one as-converted one-for-one

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 — Fair Value Measurements The following tables present information about the Company’s financial liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022, by level within the fair value hierarchy: March 31, 2023 Description Quoted Prices in Active Significant Other Significant Other Assets: Investments held in Trust Account - U.S. (1) $ 65,388,153 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 979,450 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 894,240 December 31, 2022 Description Quoted Prices in Active Significant Other Significant Other Assets: Investments held in Trust Account - U.S. (1) $ 64,703,943 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 1,295,400 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 1,182,710 (1) Includes $1,663 of cash balance held within the Trust Account as of March 31, 2023 and December 31, 2022. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in December 2022 when the Public Warrants were separately listed and traded. Level 1 assets include investments in money market funds or U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants and the private placement warrants was initially measured using Black-Scholes option pricing model and Monte-Carlo simulation method, respectively. Beginning in December 2022, the fair value of Public Warrants has been measured based on the listed market price of such Public Warrants. The estimated fair value of the private placement warrants was determined using Level 3 inputs as of March 31, 2023 and December 31, 2022. Inherent in a Black-Scholes option pricing model and a Monte-Carlo simulation method are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement date at March 31, 2023 and December 31, 2022: As of March 31, 2023 As of December 31, 2022 Exercise price $ 11.50 $ 11.50 Stock price $ 10.25 $ 10.05 Volatility 4.5 % 4.9 % Risk-free rate 3.5 % 3.90 % Dividend yield 0.0 % 0.0 % The changes in the Level 3 fair value of the derivative warrant liabilities for the three months ended March 31, 2023 are summarized as follows. There were no derivative warrant liabilities for the period from February 15, 2022 (inception) to March 31, 2022. Balance as of December 31, 2022 - Level 3 $ 1,182,710 Change in fair value of derivative warrant liabilities - Private Warrants (288,470 ) Balance as of March 31, 2023 - Level 3 $ 894,240

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the unaudited condensed financial statements, except as noted below. Subsequent to March 31, 2023, the Company withdrew $304,000 from the Trust Account to pay for its taxes.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, Article 8 and Article 10 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report Form 10-K
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, regularly exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in Trust Account in the accompanying condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, other than for the Overfunding Loan to the Sponsor, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets, either because the short-term nature of the instruments or because the instrument is recognized at fair value.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the condensed statements of operations each reporting period. The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company evaluates embedded conversion features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from the debt host instrument and accounted for as a derivative in accordance with ASC 815. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and will adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Offering Costs of Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the derivative warrant liabilities were charged to operations. Offering costs associated with the Class A common stock were charged against the carrying value of Class A common stock upon the completion of the Initial Public Offering.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption As discussed in Note 1, all of the 6,319,000 shares of Class A common stock sold as parts of the units in the Initial Public Offering contain a redemption feature. In accordance with ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. The Company classified all of the shares of Class A common stock as redeemable. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. As of March 31, 2023 and December 31, 2022, the amounts of Class A common stock reflected on the condensed balance sheets are reconciled in the following table: Gross proceeds $ 63,190,000 Less: Proceeds allocated to Public Warrants (379,140 ) Class A shares issuance costs (3,802,072 ) Plus: Accretion of carrying value to redemption value 5,353,286 Class A common stock subject to possible redemption - December 31, 2022 64,362,074 Plus: Accretion of carrying value to redemption value 452,772 Class A common stock subject to possible redemption - March 31, 2023 $ 64,814,846
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average number of common stock outstanding for the respective period. The Company has not considered the effect of the Public Warrants and the private placement warrants to purchase an aggregate of 6,044,160 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share of common stock for each class of common stock: For the period from For the three months ended February 15, 2022 (inception) March 31, 2023 through March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per common share: Numerator: Allocation of net income (loss) $ 421,594 $ 105,398 $ — $ (41,000 ) Denominator: Basic and diluted weighted average common shares outstanding 6,319,000 1,579,750 — 1,500,000 Basic and diluted net income (loss) per common share $ 0.07 $ 0.07 $ — $ (0.03 )
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2023 and December 31, 2022, the Company had gross deferred tax assets of approximately $ respectively, which were presented net of a full valuation allowance. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.
Recent Accounting Standards	Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Class A Ordinary Shares Reflected On the Balance Sheet	As of March 31, 2023 and December 31, 2022, the amounts of Class A common stock reflected on the condensed balance sheets are reconciled in the following table: Gross proceeds $ 63,190,000 Less: Proceeds allocated to Public Warrants (379,140 ) Class A shares issuance costs (3,802,072 ) Plus: Accretion of carrying value to redemption value 5,353,286 Class A common stock subject to possible redemption - December 31, 2022 64,362,074 Plus: Accretion of carrying value to redemption value 452,772 Class A common stock subject to possible redemption - March 31, 2023 $ 64,814,846
Summary Of Earnings Per Share, Basic And Diluted	The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share of common stock for each class of common stock: For the period from For the three months ended February 15, 2022 (inception) March 31, 2023 through March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per common share: Numerator: Allocation of net income (loss) $ 421,594 $ 105,398 $ — $ (41,000 ) Denominator: Basic and diluted weighted average common shares outstanding 6,319,000 1,579,750 — 1,500,000 Basic and diluted net income (loss) per common share $ 0.07 $ 0.07 $ — $ (0.03 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fairvalue Assets And Liabilities Measured On Recurring And Nonrecurring Basis	The following tables present information about the Company’s financial liabilities that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022, by level within the fair value hierarchy: March 31, 2023 Description Quoted Prices in Active Significant Other Significant Other Assets: Investments held in Trust Account - U.S. (1) $ 65,388,153 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 979,450 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 894,240 December 31, 2022 Description Quoted Prices in Active Significant Other Significant Other Assets: Investments held in Trust Account - U.S. (1) $ 64,703,943 $ — $ — Liabilities: Derivative warrant liabilities - Public $ 1,295,400 $ — $ — Derivative warrant liabilities - Private $ — $ — $ 1,182,710 (1) Includes $1,663 of cash balance held within the Trust Account as of March 31, 2023 and December 31, 2022.
Schedule of Fair Value Measurement Inputs and Valuation	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement date at March 31, 2023 and December 31, 2022: As of March 31, 2023 As of December 31, 2022 Exercise price $ 11.50 $ 11.50 Stock price $ 10.25 $ 10.05 Volatility 4.5 % 4.9 % Risk-free rate 3.5 % 3.90 % Dividend yield 0.0 % 0.0 %
Schedule of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation	The changes in the Level 3 fair value of the derivative warrant liabilities for the three months ended March 31, 2023 are summarized as follows. There were no derivative warrant liabilities for the period from February 15, 2022 (inception) to March 31, 2022. Balance as of December 31, 2022 - Level 3 $ 1,182,710 Change in fair value of derivative warrant liabilities - Private Warrants (288,470 ) Balance as of March 31, 2023 - Level 3 $ 894,240

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)					1 Months Ended	2 Months Ended	3 Months Ended	11 Months Ended
	Oct. 11, 2022	Oct. 04, 2022	Aug. 16, 2022	Mar. 03, 2022	May 15, 2023	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Deferred Underwriting Commissions Noncurrent							$ 2,100,000
Proceeds from the issuance of common stock						$ 25,000	$ 0
Payments to Acquire Restricted Investments	$ 64,100,000
Term of restricted investments	185 days
Payment per share to acquire restricted shares	$ 10.15
Temporary equity redemption price per share							$ 10.15
Minimum Net Worth Required for Compliance							$ 5,000,001
Percentage of public shares that can be transferred without any restriction							15%
Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination							100%
Business combination period							21 months
Debt instrument amount to be contributed per share							$ 0.1
Threshold number of business days for redemption							10 days
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities							$ 100,000
Per share amount in the trust account minimum							$ 10.15
Per share amount in the trust account maximum							$ 10.15
Net working capital							$ 644,000
Income taxes payable by interest income in trust							473,000
Cash consideration							$ 1,200
On Or After First January Two Thousand And Twenty Three [Member] | Inflation Reduction Act Of Two Thousand And Twenty Two [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of excise tax			1%
Percentage of excise tax on certain share repurchases			1%
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Prospective assets of acquire as a percentage of fair value of assets in the trust account							80%
Business combination period							15 months
Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Business combination period							21 months
Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital loans convertible into equity warrants							$ 1,500,000
Bank overdrafts							0	$ 0
Sponsor [Member] | Initial Overfunding Loan [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from related party debt	$ 900,000
Debt instrument, face amount		$ 900,000
Sponsor [Member] | Additional Overfunding Loan [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from related party debt	47,850
Debt instrument, face amount	$ 47,850
Sponsor [Member] | Extension Loans [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Debt instrument, face amount							$ 631,900
Debt instrument, convertible, conversion price							$ 1
Sponsor [Member] | Promissory Note [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from related party debt				$ 145,000
Debt instrument, face amount							$ 145,000
Sponsor [Member] | Working Capital Loans [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital loans convertible into equity warrants							$ 1,500,000
Debt instrument, convertible, conversion price							$ 1
Bank overdrafts							$ 0	0
Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights issue of warrants during the period units							2,840,000
Class of warrants or rights issue price per share							$ 1
Proceeds from the issuance of warrants							$ 2,800,000
Additional Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights issue of warrants during the period units	44,660
Class of warrants or rights issue price per share	$ 1
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Shares issued price per share		$ 10
Deferred Underwriting Fee							$ 112,000
Private Placement [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights issue of warrants during the period units		2,840,000
Class of warrants or rights issue price per share		$ 1
Proceeds from the issuance of warrants		$ 2,800,000
Private Placement [Member] | Additional Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights issue of warrants during the period units	44,660
Class of warrants or rights issue price per share	$ 1
Proceeds from the issuance of warrants	$ 45,000
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from issuance initial public offering								$ 63,190,000
Temporary equity redemption price per share							$ 10.26	$ 10.19
Common Class A [Member] | IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares new issues		6,000,000
Shares issued price per share		$ 10
Proceeds from issuance initial public offering		$ 60,000,000
Deferred Underwriting Commissions Noncurrent		2,100,000
Offering Costs Allocated To Derivative Warrant Liabilities		26,000
Payment of stock issuance costs		$ 3,700,000
Common Class A [Member] | Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares new issues	319,000
Deferred Underwriting Fee	$ 112,000
Payment of stock issuance costs	156,000
Proceeds from the issuance of common stock	$ 3,200,000
Common Class B [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from the issuance of common stock								$ 25,000
Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Amount drawn from trust account to pay taxes					$ 304,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Line Items]
Cash equivalents at carrying value	$ 0	$ 0
Cash FDIC insured amount	250,000
Unrecognized tax benefits	0	0
Unrecognized tax benefits income tax penalties and interest accrued	$ 0	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Class A Ordinary Shares Reflected On the Condensed Balance Sheets (Detail) - USD ($)	3 Months Ended	11 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Accretion of carrying value to redemption value	$ 452,772
Class A common stock subject to possible redemption	64,814,846	$ 64,362,074
Common Class A [Member]
Temporary Equity [Line Items]
Gross proceeds		63,190,000
Proceeds allocated to Public Warrants		(379,140)
Class A shares issuance costs		(3,802,072)
Accretion of carrying value to redemption value	452,772	5,353,286
Class A common stock subject to possible redemption	$ 64,814,846	$ 64,362,074

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary Of Earnings Per Share, Basic And Diluted (Detail) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023
Numerator:
Allocation of net income (loss)	$ (41,000)	$ 526,992
Common Class A [Member]
Numerator:
Allocation of net income (loss)	$ 0	$ 421,594
Denominator:
Weighted average shares outstanding, basic	0	6,319,000
Weighted average shares outstanding, diluted	0	6,319,000
Basic net income (loss) per share	$ 0	$ 0.07
Diluted net income (loss) per share	$ 0	$ 0.07
Common Class B [Member]
Numerator:
Allocation of net income (loss)	$ (41,000)	$ 105,398
Denominator:
Weighted average shares outstanding, basic	1,500,000	1,579,750
Weighted average shares outstanding, diluted	1,500,000	1,579,750
Basic net income (loss) per share	$ (0.03)	$ 0.07
Diluted net income (loss) per share	$ (0.03)	$ 0.07

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	11 Months Ended
	Dec. 31, 2022	Mar. 31, 2023
Investment threshold period	185 days
Deferred tax assets	$ 196,000	$ 111,000
Common Class A [Member]
Temporary equity, shares outstanding	6,319,000	6,319,000
Common Class A [Member] | Warrant [Member]
Warrant to purchase common stock shares		6,044,160

Initial Public Offering (Detail

Initial Public Offering (Detail) - USD ($)			2 Months Ended	3 Months Ended	11 Months Ended
	Oct. 11, 2022	Oct. 04, 2022	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Initial Public Offering Disclosure [Line Items]
Deferred underwriting commissions noncurrent				$ 2,100,000
Proceeds from the issuance of common stock			$ 25,000	$ 0
Class of warrants or rights number of securities covered by each warrant or right				0.361
Class of warrants or rights exercise price of warrants or rights				$ 11.5
Common Class A [Member]
Initial Public Offering Disclosure [Line Items]
Proceeds from issuance initial public offering					$ 63,190,000
Common Class A [Member] | Public Warrant [Member]
Initial Public Offering Disclosure [Line Items]
Class of warrants or rights number of securities covered by each warrant or right				1
Class of warrants or rights exercise price of warrants or rights				$ 11.5
IPO [Member] | Common Class A [Member]
Initial Public Offering Disclosure [Line Items]
Stock issued during the period shares new issues		6,000,000
Shares issued price per share		$ 10
Proceeds from issuance initial public offering		$ 60,000,000
Payment of stock issuance costs		3,700,000
Deferred underwriting commissions noncurrent		2,100,000
Offering costs allocated to derivative warrant liabilities		$ 26,000
Over-Allotment Option [Member]
Initial Public Offering Disclosure [Line Items]
Shares issued price per share		$ 10
Overallotment option vesting period		45 days
Common stock shares subscribed but not issued		900,000
Deferred underwriting fee				$ 112,000
Over-Allotment Option [Member] | Common Class A [Member]
Initial Public Offering Disclosure [Line Items]
Stock issued during the period shares new issues	319,000
Payment of stock issuance costs	$ 156,000
Proceeds from the issuance of common stock	3,200,000
Deferred underwriting fee	$ 112,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)							3 Months Ended	11 Months Ended
	Oct. 11, 2022	Oct. 04, 2022	Sep. 29, 2022	Sep. 08, 2022	Mar. 16, 2022	Mar. 03, 2022	Mar. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Class of warrants or rights number of securities covered by each warrant or right							0.361
Class of warrant or right, exercise price of warrants or rights							$ 11.5
Business combination period							21 months
Promissory Note [Member]
Related Party Transaction [Line Items]
Notes payable to related party current							$ 0
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants or rights issue of warrants during the period units							2,840,000
Class of warrants or rights issue price per share							$ 1
Proceeds from the issuance of warrants							$ 2,800,000
Additional Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants or rights issue of warrants during the period units	44,660
Class of warrants or rights issue price per share	$ 1
Proceeds from issuance of private placement	$ 45,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Shares issued, Price per share		$ 10
Private Placement [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants or rights issue of warrants during the period units		2,840,000
Class of warrants or rights issue price per share		$ 1
Proceeds from the issuance of warrants		$ 2,800,000
Private Placement [Member] | Additional Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrants or rights issue of warrants during the period units	44,660
Class of warrants or rights issue price per share	$ 1
Proceeds from the issuance of warrants	$ 45,000
Common Class A [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding							6,319,000	6,319,000
Common Class A [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right, exercise price of warrants or rights							$ 11.5
Common Class A [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Class of warrants or rights number of securities covered by each warrant or right							1
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding			1,725,000		1,725,000		1,579,750	1,579,750
Stock surrendered during the period shares			431,250	718,750
Common Class B [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Common stock shares subject to forfeiture							225,000
Founder [Member] | Common Class B [Member]
Related Party Transaction [Line Items]
Stock issued during period, shares, issued for services					2,875,000
Shares issued, Price per share					$ 0.0001
Stock issued during period, value, issued for services					$ 25,000
Common stock shares outstanding							1,725,000
Stock surrendered during the period shares			431,250	718,750
Founder [Member] | Common Class B [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Common stock shares subject to forfeiture							225,000
Stock forfeited during the period shares	145,250
Sponsor [Member]
Related Party Transaction [Line Items]
Working capital loans convertible into equity warrants							$ 1,500,000
Bank overdrafts							0	$ 0
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount							$ 145,000
Proceeds from notes payable to related party current						$ 200,000
Proceeds from Related Party Debt						$ 145,000
Sponsor [Member] | Initial Overfunding Loan [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount		900,000
Proceeds from Related Party Debt	$ 900,000
Sponsor [Member] | Additional Overfunding Loan [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount	47,850
Proceeds from Related Party Debt	47,850
Sponsor [Member] | OverFunding Loans [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount	$ 947,850
Number of days after which business combination within which securities registration shall be effective							60 days
Sponsor [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Debt instrument, convertible, conversion price							$ 1
Working capital loans convertible into equity warrants							$ 1,500,000
Bank overdrafts							0	0
Sponsor [Member] | Extension Loans [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount							$ 631,900
Debt instrument, convertible, conversion price							$ 1
Sponsor [Member] | Administration And Support Services [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction		$ 10,000
Sponsor [Member] | Administrative Service Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, selling, general and administrative expenses from transactions with related party							$ 30,000
Related party transaction prepaid expenses from transactions with related party							$ 20,000	$ 50,000
Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Lock in period of warrants							30 days
Sponsor [Member] | Common Class A [Member]
Related Party Transaction [Line Items]
Common stock shares lock in period							1 year
Share price							$ 12
Number of trading days for determining share price							20 days
Number of consecutive trading days for determining the share price							30 days
Waiting period after which the share trading days are considered							150 days
Sponsor [Member] | Common Class A [Member] | OverFunding Loans [Member]
Related Party Transaction [Line Items]
Debt instrument, convertible, conversion price							$ 10
Sponsor [Member] | Common Class A [Member] | Extension Loans [Member]
Related Party Transaction [Line Items]
Share price							$ 0.1
Sponsor [Member] | Founder [Member] | Common Class B [Member]
Related Party Transaction [Line Items]
Percentage of common stock issued and outstanding							20%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	2 Months Ended
	Mar. 31, 2022	Mar. 31, 2023
Loss Contingencies [Line Items]
Underwriting discount	$ 0.14
Underwriting discount aggregate amount	$ 800,000
Additional fee per unit	$ 0.35
Deferred Underwriting Commissions Noncurrent		$ 2,100,000
Over-Allotment Option [Member]
Loss Contingencies [Line Items]
Underwriting discount aggregate amount	$ 45,000
Deferred Underwriting Fee		$ 112,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	2 Months Ended	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023
Schedule Of Derivative Warrant Liabilities [Line Items]
Class of Warrant or Right, Outstanding		6,044,160
Class of warrant or right, exercise price of warrants or rights		$ 11.5
Proceeds from equity used for funding business combination as a percentage of the total	60%
Number of consecutive trading days for determining volume weighted average price of shares	20 days
Number of trading days for determining the share price	10 days
Class of warrants or rights number of securities covered by each warrant or right		0.361
Common Class A [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Threshold issue price for capital raising purpose in connection with closing of business combination		$ 9.2
Warrant exercise price, description		the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price
Public Warrants [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Class of Warrant or Right, Outstanding		3,159,500
Number of days after consummation of business combination within which the securities shall be registered	15 days
Number of days after which business combination within which securities registration shall be effective	60 days
Warrants and rights outstanding term		5 years
Public Warrants [Member] | Common Class A [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Volume weighted average price per share	$ 9.2
Public Warrants [Member] | Common Class A [Member] | Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Share price		$ 18
Class of warrants or rights redemption price per unit		0.01%
Minimum notice period to be given to the holders of warrants		30 days
Number of trading days for determining the share price		20 days
Number of consecutive trading days for determining the share price		30 days
Public Warrants [Member] | Common Class A [Member] | Share Price Equal Or Exceeds Ten Rupees Per Dollar [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Share price		$ 10
Class of warrants or rights redemption price per unit		0.10%
Minimum notice period to be given to the holders of warrants		30 days
Number of trading days for determining the share price		20 days
Number of consecutive trading days for determining the share price		30 days
Public Warrants [Member] | After the completion of a Business Combination [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Period after which the warrants are exercisable	30 days
Public Warrants [Member] | From the closing of the Initial Public Offering [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Period after which the warrants are exercisable	12 months
Private Placement Warrants [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Class of Warrant or Right, Outstanding		2,884,660
Private Placement Warrants [Member] | Common Class A [Member]
Schedule Of Derivative Warrant Liabilities [Line Items]
Class of warrant or right, exercise price of warrants or rights		$ 11.5

Shareholders' Deficit - Additio

Shareholders' Deficit - Additional Information (Detail) - $ / shares		3 Months Ended
	Oct. 11, 2022	Mar. 31, 2023	Dec. 31, 2022	Sep. 29, 2022	Mar. 16, 2022
Class of Stock [Line Items]
Preferred stock shares authorized		1,000,000	1,000,000
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001
Preferred stock shares issued		0	0
Preferred stock shares outstanding		0	0
Conversion of Class B To Class A Common Stock [Member]
Class of Stock [Line Items]
Common stock, voting rights		one vote
Percentage of the total number of ordinary shares outstanding after conversion		20%
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized		35,000,000	35,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares issued		6,319,000	6,319,000
Common stock shares outstanding		6,319,000	6,319,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized		5,000,000	5,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares issued		1,579,750	1,579,750		1,725,000
Common stock shares outstanding		1,579,750	1,579,750	1,725,000	1,725,000
Percentage of common stock issued and outstanding after the initial public offering		20%
Common Class B [Member] | Over-Allotment Option [Member]
Class of Stock [Line Items]
Common stock shares subject to forfeiture		225,000
Stock forfeiture during the period	145,250

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fairvalue Assets And Liabilities Measured On Recurring And Nonrecurring Basis (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Derivative Liability, Noncurrent	Derivative Liability, Noncurrent
Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash balance held within the Trust Account	$ 1,663	$ 1,663
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	979,450	1,295,400
Fair Value, Inputs, Level 1 [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Fair Value, Inputs, Level 1 [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash balance held within the Trust Account	65,388,153	64,703,943
Fair Value, Inputs, Level 2 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Fair Value, Inputs, Level 2 [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Fair Value, Inputs, Level 2 [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash balance held within the Trust Account	0	0
Fair Value, Inputs, Level 3 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Fair Value, Inputs, Level 3 [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	894,240	1,182,710
Fair Value, Inputs, Level 3 [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash balance held within the Trust Account	$ 0	$ 0

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation (Detail) - Fair Value, Inputs, Level 3 [Member]	Mar. 31, 2023	Dec. 31, 2022
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	11.5	11.5
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	10.25	10.05
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	4.5	4.9
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	3.5	3.9
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	0	0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2023
Fair Value Disclosure [Line Items]
Derivative warrant liabilities	$ 0	$ (604,420)
Derivative [Member]
Fair Value Disclosure [Line Items]
Derivative warrant liabilities	$ 0

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation (Detail)	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance as of December 31, 2022 - Level 3	$ 1,182,710
Change in fair value of derivative warrant liabilities - Private Warrants	(288,470)
Balance as of March 31, 2023 - Level 3	$ 894,240

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail)	1 Months Ended
	May 15, 2023 USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Amount drawn from trust account to pay taxes	$ 304,000